Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
Standard Solutions01:14

Standard Solutions

Standard solutions refer to solutions with a precisely known concentration or composition. A primary standard is a highly pure, high molar mass, stable substance that is entirely soluble in water, the most commonly used solvent in analytical chemistry. The primary standard solution can be used to standardize secondary standards, which are substances with known concentrations but are less pure and stable. Standard solutions are essential for achieving accurate and reliable results in analytical...
Pharmaceutical Equivalents01:26

Pharmaceutical Equivalents

As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
Drug Nomenclature01:17

Drug Nomenclature

During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that the same...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Change in surface characteristics and permeability of human enamel after subjecting to radiation therapy.

Nigerian journal of clinical practice·2022
Same author

Sources of SARS-CoV-2 and Other Microorganisms in Dental Aerosols.

Journal of dental research·2021
Same author

Subgingival Host-Microbial Interactions in Hyperglycemic Individuals.

Journal of dental research·2020
Same author

Dataset on the suitability of groundwater for drinking and irrigation purposes in the Sarabanga River region, Tamil Nadu, India.

Data in brief·2020
Same author

Novel Nicotine Delivery Systems.

Advances in dental research·2019
Same author

Topic: Inguinal Hernia - Unsolved problem in the daily practice.

Hernia : the journal of hernias and abdominal wall surgery·2015

Related Experiment Video

Updated: May 22, 2026

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

Standardisation of ayurvedic oils.

P T Hepsibah1, N B Prasad, P S Kumar

  • 1Drug Standardisation Unit, Ayurveda Research Institute, Poojappura, Trivandrum - 695 012, Kerala, India.

Ancient Science of Life
|May 5, 2012
PubMed
Summary

This study establishes physico-chemical standards for Karpooradi taila, a medicated oil for treating Varrthavikaram. These standards, including Thin Layer chromatography, serve as a unique fingerprint for quality control of Karpooradi taila.

Area of Science:

  • Ayurvedic medicine
  • Pharmacognosy
  • Quality control of herbal medicines

Background:

  • Karpooradi taila is a traditional Ayurvedic medicated oil.
  • It is utilized for the management of a condition known as Varrthavikaram.
  • Standardization is crucial for ensuring the efficacy and safety of herbal formulations.

Purpose of the Study:

  • To establish essential physico-chemical standards for Karpooradi taila.
  • To develop a reliable fingerprinting method for quality assessment.
  • To ensure consistency and therapeutic value of the medicated oil.

Main Methods:

  • Physico-chemical analysis of Karpooradi taila samples.
  • Determination of key parameters like viscosity, refractive index, and specific gravity.

More Related Videos

An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules
05:59

An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules

Published on: November 4, 2022

Related Experiment Videos

Last Updated: May 22, 2026

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules
05:59

An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules

Published on: November 4, 2022

  • Thin Layer Chromatography (TLC) for chromatographic profiling.
  • Main Results:

    • Defined specific physico-chemical standards for Karpooradi taila.
    • Established a characteristic Thin Layer chromatographic pattern.
    • Demonstrated the utility of these parameters as a fingerprint standard.

    Conclusions:

    • The identified physico-chemical standards are suitable for routine quality control.
    • The Thin Layer chromatographic pattern provides a reliable method for identification and authentication.
    • These standards will aid in ensuring the quality and consistency of Karpooradi taila.